Penticin is a medication containing a combination of Flupentixol and Melitracen.

Flupentixol is a neuroleptic drug with anxiolytic and antidepressant properties when given in small doses.

Melitracen is a bipolar thymoleptic with activating properties in low doses.

Indications:

Penticin is used to treat:

• Anxiety 
• Depression 
• Apathy 
• Psychogenic depression 
• Depressive neuroses 
• Masked depression 
• Psychosomatic affections accompanied by anxiety and apathy 
• Menopausal depressions 
• Dysphoria and depression in alcoholicsand drug addicts  

Dosage and Administration:  

• Adults:Usually2 tablets orally daily, in the morning and at noon. In severe cases, the morning dose may be increased to 2 tablets. 
• Elderly patients:1 tablet in the morning. 
• Maintenance dose:Usually 1 tablet orally in the morning.Additional sedative treatment may be recommended for insomnia or severe restlessness in the acute phase.

Contraindications:

• Immediate recovery phase after myocardial infarction. 
• Defects in bundle-branch conduction. 
• Untreated narrow-angle glaucoma. 
• Acute alcohol, barbiturate and opiate intoxications. 
• Patients who have received an MAO-inhibitor within two weeks.
• Not recommended for excitable or overactive patients.

Side Effects:

Side effects are rare at recommended doses. They may include transient restlessness and insomnia.

Pregnancy and Lactation:

Penticin should preferably not be given during pregnancy and lactation.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.